Loading
companiesCompany
CanCertain
CanCertain grows circulating tumour cells from a blood sample in 3D culture and tests drugs on them, including immunotherapies, and accepts orders from patients as well as physicians.
Also called: CLYZ Labs
Overview
CanCertain, run by the UK laboratory CLYZ Labs, isolates circulating tumour cells from blood, expands them in 3D cell culture and exposes them to cancer drugs to report which show activity, an approach compatible with immunotherapy testing. Patient- or physician-ordered.
Similar pages
- CompanyCNSide Diagnostics
Shares Circulating tumour cell capture and the tag fcct-directory.
- CompanyRGCC International
Shares Circulating tumour cell capture and the tag fcct-directory.
- CompanyTravera
Shares Functional (ex vivo) drug testing and the tag fcct-directory.
- CompanyFirst Ascent Biomedical
Shares Functional (ex vivo) drug testing and the tag fcct-directory.
- Company2cureX
Shares Functional (ex vivo) drug testing and the tag fcct-directory.
- CompanyCure-First
Shares Functional (ex vivo) drug testing and the tag fcct-directory.
- CompanySageMedic
Shares Functional (ex vivo) drug testing and the tag fcct-directory.
- CompanySpeciCare
Shares Functional (ex vivo) drug testing and the tag fcct-directory.